Quince Therapeutics
QNCX
QNCX
86 hedge funds and large institutions have $490M invested in Quince Therapeutics in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
41% less capital invested
Capital invested by funds: $827M → $490M (-$337M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
78% less call options, than puts
Call options by funds: $4.01M | Put options by funds: $17.9M
Holders
86
Holding in Top 10
1
Calls
$4.01M
Puts
$17.9M
Top Buyers
| 1 | +$15M | |
| 2 | +$11.1M | |
| 3 | +$4.14M | |
| 4 |
Millennium Management
New York
|
+$2.89M |
| 5 |
ECG
EPIQ Capital Group
San Francisco,
California
|
+$2.56M |
Top Sellers
| 1 | -$6.17M | |
| 2 | -$1.44M | |
| 3 | -$1.4M | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.09M |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$859K |